Centhaquine clinical trials
Also written PMZ-2010.
How each study uses centhaquine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the centhaquine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2014 (1); 2 more planned to start later
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Pharmazz, Inc. (6)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test centhaquine.
- Nov 2026A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock PatientsPhase 4 · Pharmazz, Inc.
- Oct 2027Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDSPhase 2 · Pharmazz, Inc.
Studies
Open first, then newest update. How each study uses centhaquine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDSNot yet recruitingPhase 2Pharmazz, Inc.NCT05241067Written as Centhaquine
- A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative AgentNot yet recruitingPhase 3Pharmazz, Inc.NCT05251181Written as Centhaquine
- A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock PatientsRecruitingPhase 4Pharmazz, Inc.NCT05956418Written as Centhaquine
- Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic ShockCompletedPhase 3Pharmazz, Inc.NCT04045327Written as Centhaquine + Standard Treatment
- PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic ShockCompletedPhase 2Pharmazz, Inc.NCT04056065Written as Centhaquine
- A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy VolunteersCompletedPhase 1Pharmazz, Inc.NCT02408731Written as PMZ-2010 (Centhaquin)
Codes
What other systems call centhaquine · ClinicalTrials.gg INT003223
- MeSH (NLM) C045913centhaquineOne source ClinicalTrials.gov
- UNII (FDA) QD4VI0J9T5CENTHAQUINEConfirmed FDA, Wikidata
- Wikidata Q83080535centhaquineConfirmed FDA, Wikidata
- NCI Thesaurus C171678CenthaquineOne source FDA
- DrugBank DB16122One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C045913 | centhaquine | One source ClinicalTrials.gov |
| UNII (FDA) | QD4VI0J9T5 | CENTHAQUINE | Confirmed FDA, Wikidata |
| Wikidata | Q83080535 | centhaquine | Confirmed FDA, Wikidata |
| NCI Thesaurus | C171678 | Centhaquine | One source FDA |
| DrugBank | DB16122 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.